Cargando…

Clinician Perspectives on Clinical Decision Support for Familial Hypercholesterolemia

Familial Hypercholesterolemia (FH) is underdiagnosed in the United States. Clinical decision support (CDS) could increase FH detection once implemented in clinical workflows. We deployed CDS for FH at an academic medical center and sought clinician insights using an implementation survey. In Novembe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bangash, Hana, Elsekaily, Omar, Saadatagah, Seyedmohammad, Sutton, Joseph, Johnsen, Paul, Gundelach, Justin H., Kamzabek, Arailym, Freimuth, Robert, Caraballo, Pedro J., Kullo, Iftikhar J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305024/
https://www.ncbi.nlm.nih.gov/pubmed/37373918
http://dx.doi.org/10.3390/jpm13060929
_version_ 1785065636631674880
author Bangash, Hana
Elsekaily, Omar
Saadatagah, Seyedmohammad
Sutton, Joseph
Johnsen, Paul
Gundelach, Justin H.
Kamzabek, Arailym
Freimuth, Robert
Caraballo, Pedro J.
Kullo, Iftikhar J.
author_facet Bangash, Hana
Elsekaily, Omar
Saadatagah, Seyedmohammad
Sutton, Joseph
Johnsen, Paul
Gundelach, Justin H.
Kamzabek, Arailym
Freimuth, Robert
Caraballo, Pedro J.
Kullo, Iftikhar J.
author_sort Bangash, Hana
collection PubMed
description Familial Hypercholesterolemia (FH) is underdiagnosed in the United States. Clinical decision support (CDS) could increase FH detection once implemented in clinical workflows. We deployed CDS for FH at an academic medical center and sought clinician insights using an implementation survey. In November 2020, the FH CDS was deployed in the electronic health record at all Mayo Clinic sites in two formats: a best practice advisory (BPA) and an in-basket alert. Over three months, 104 clinicians participated in the survey (response rate 11.1%). Most clinicians (81%) agreed that CDS implementation was a good option for identifying FH patients; 78% recognized the importance of implementing the tool in practice, and 72% agreed it would improve early diagnosis of FH. In comparing the two alert formats, clinicians found the in-basket alert more acceptable (p = 0.036) and more feasible (p = 0.042) than the BPA. Overall, clinicians favored implementing the FH CDS in clinical practice and provided feedback that led to iterative refinement of the tool. Such a tool can potentially increase FH detection and optimize patient management.
format Online
Article
Text
id pubmed-10305024
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103050242023-06-29 Clinician Perspectives on Clinical Decision Support for Familial Hypercholesterolemia Bangash, Hana Elsekaily, Omar Saadatagah, Seyedmohammad Sutton, Joseph Johnsen, Paul Gundelach, Justin H. Kamzabek, Arailym Freimuth, Robert Caraballo, Pedro J. Kullo, Iftikhar J. J Pers Med Communication Familial Hypercholesterolemia (FH) is underdiagnosed in the United States. Clinical decision support (CDS) could increase FH detection once implemented in clinical workflows. We deployed CDS for FH at an academic medical center and sought clinician insights using an implementation survey. In November 2020, the FH CDS was deployed in the electronic health record at all Mayo Clinic sites in two formats: a best practice advisory (BPA) and an in-basket alert. Over three months, 104 clinicians participated in the survey (response rate 11.1%). Most clinicians (81%) agreed that CDS implementation was a good option for identifying FH patients; 78% recognized the importance of implementing the tool in practice, and 72% agreed it would improve early diagnosis of FH. In comparing the two alert formats, clinicians found the in-basket alert more acceptable (p = 0.036) and more feasible (p = 0.042) than the BPA. Overall, clinicians favored implementing the FH CDS in clinical practice and provided feedback that led to iterative refinement of the tool. Such a tool can potentially increase FH detection and optimize patient management. MDPI 2023-05-31 /pmc/articles/PMC10305024/ /pubmed/37373918 http://dx.doi.org/10.3390/jpm13060929 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Bangash, Hana
Elsekaily, Omar
Saadatagah, Seyedmohammad
Sutton, Joseph
Johnsen, Paul
Gundelach, Justin H.
Kamzabek, Arailym
Freimuth, Robert
Caraballo, Pedro J.
Kullo, Iftikhar J.
Clinician Perspectives on Clinical Decision Support for Familial Hypercholesterolemia
title Clinician Perspectives on Clinical Decision Support for Familial Hypercholesterolemia
title_full Clinician Perspectives on Clinical Decision Support for Familial Hypercholesterolemia
title_fullStr Clinician Perspectives on Clinical Decision Support for Familial Hypercholesterolemia
title_full_unstemmed Clinician Perspectives on Clinical Decision Support for Familial Hypercholesterolemia
title_short Clinician Perspectives on Clinical Decision Support for Familial Hypercholesterolemia
title_sort clinician perspectives on clinical decision support for familial hypercholesterolemia
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305024/
https://www.ncbi.nlm.nih.gov/pubmed/37373918
http://dx.doi.org/10.3390/jpm13060929
work_keys_str_mv AT bangashhana clinicianperspectivesonclinicaldecisionsupportforfamilialhypercholesterolemia
AT elsekailyomar clinicianperspectivesonclinicaldecisionsupportforfamilialhypercholesterolemia
AT saadatagahseyedmohammad clinicianperspectivesonclinicaldecisionsupportforfamilialhypercholesterolemia
AT suttonjoseph clinicianperspectivesonclinicaldecisionsupportforfamilialhypercholesterolemia
AT johnsenpaul clinicianperspectivesonclinicaldecisionsupportforfamilialhypercholesterolemia
AT gundelachjustinh clinicianperspectivesonclinicaldecisionsupportforfamilialhypercholesterolemia
AT kamzabekarailym clinicianperspectivesonclinicaldecisionsupportforfamilialhypercholesterolemia
AT freimuthrobert clinicianperspectivesonclinicaldecisionsupportforfamilialhypercholesterolemia
AT caraballopedroj clinicianperspectivesonclinicaldecisionsupportforfamilialhypercholesterolemia
AT kulloiftikharj clinicianperspectivesonclinicaldecisionsupportforfamilialhypercholesterolemia